Log in

FRA:SRT3 - Sartorius Stock Price, Forecast & News

€212.00
-3.09 (-1.44 %)
(As of 03/27/2020 04:00 PM ET)
Today's Range
€203.20
Now: €212.00
€214.40
50-Day Range
€177.90
MA: €214.08
€240.00
52-Week Range
€71.00
Now: €212.00
€124.70
Volume79,886 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, food and beverage, environmental, and paint mixing industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Read More
Sartorius logo

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-551-3080

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees8,500
Next Earnings DateN/A
OptionableNot Optionable

Receive SRT3 News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT3 and its competitors with MarketBeat's FREE daily newsletter.


Sartorius (FRA:SRT3) Frequently Asked Questions

How has Sartorius' stock been impacted by COVID-19 (Coronavirus)?

Sartorius' stock was trading at €199.00 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SRT3 stock has increased by 6.5% and is now trading at €212.00. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Sartorius?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius in the last year. There are currently 3 sell ratings, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Sartorius.

What price target have analysts set for SRT3?

9 analysts have issued 1 year price targets for Sartorius' shares. Their forecasts range from €128.00 to €235.00. On average, they expect Sartorius' share price to reach €177.00 in the next year. This suggests that the stock has a possible downside of 16.5%. View analysts' price targets for Sartorius.

Has Sartorius been receiving favorable news coverage?

News headlines about SRT3 stock have trended very positive on Saturday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Sartorius earned a news sentiment score of 4.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutSartorius.

Who are some of Sartorius' key competitors?

What other stocks do shareholders of Sartorius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius investors own include Symrise (SY1), Osram Licht (OSR), Merck KGaA (MRK), Kion Group (KGX), Henkel AG & Co KGaA (HEN3), Deutsche Telekom (DTE), Allianz (ALV), adidas (ADS), Volkswagen (VOW3) and Daimler (DAI).

Who are Sartorius' key executives?

Sartorius' management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)
  • Mr. Rainer Lehmann, CFO & Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 43)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)
  • Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43)

What is Sartorius' stock symbol?

Sartorius trades on the FRA under the ticker symbol "SRT3."

What is Sartorius' stock price today?

One share of SRT3 stock can currently be purchased for approximately €212.00.

What is Sartorius' official website?

The official website for Sartorius is http://www.sartorius.de/.

How can I contact Sartorius?

Sartorius' mailing address is Weender Landstrasse 94-108, GOETTINGEN, 37075, Germany. The company can be reached via phone at +49-551-3080.


MarketBeat Community Rating for Sartorius (FRA SRT3)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  105 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  266
MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SRT3 will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRT3 will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel